ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 64,545,073
- Share change
- +474,772
- Total reported value
- $887,423,123
- Put/Call ratio
- 0%
- Price per share
- $13.76
- Number of holders
- 141
- Value change
- +$4,039,525
- Number of buys
- 80
- Number of sells
- 57
Quarterly Holders Quick Answers
What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 77313F106:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
14%
|
15,802,802
|
$250,632,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
3,472,641
|
$55,076,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
3,349,160
|
$53,118,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3%
|
3,331,368
|
$52,835,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
2,753,647
|
$43,673,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.3%
|
2,502,386
|
$39,688,000 | — | 31 Mar 2022 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2%
|
2,193,725
|
$34,792,000 | — | 31 Mar 2022 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2%
|
2,133,166
|
$33,832,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
2,107,149
|
$33,419,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
1,786,255
|
$28,330,000 | — | 31 Mar 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
1,678,090
|
$26,615,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,551,774
|
$24,612,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,486,688
|
$23,578,000 | — | 31 Mar 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$23,252,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
1,346,368
|
$21,353,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.2%
|
1,320,561
|
$20,944,000 | — | 31 Mar 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,265,900
|
$20,077,000 | — | 31 Mar 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.06%
|
63,000
|
$17,884,000 | — | 31 Mar 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.92%
|
1,000,000
|
$15,860,000 | — | 31 Mar 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.79%
|
868,550
|
$13,775,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.77%
|
837,915
|
$13,289,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
748,737
|
$11,874,000 | — | 31 Mar 2022 | |
| M28 Capital Management LP |
13F
|
Company |
0.66%
|
715,880
|
$11,354,000 | — | 31 Mar 2022 | |
| Novo Holdings A/S |
13F
|
Company |
0.56%
|
612,822
|
$9,719,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.46%
|
505,544
|
$8,018,000 | — | 31 Mar 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.39%
|
427,851
|
$6,786,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.38%
|
415,265
|
$6,586,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
410,456
|
$6,510,000 | — | 31 Mar 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.36%
|
391,700
|
$6,212,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.3%
|
328,573
|
$5,211,168 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
323,172
|
$5,126,000 | — | 31 Mar 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.28%
|
303,975
|
$4,821,000 | — | 31 Mar 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.27%
|
300,000
|
$4,758,000 | — | 31 Mar 2022 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.25%
|
272,731
|
$4,456,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
273,851
|
$4,343,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
286,049
|
$4,325,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.25%
|
271,664
|
$4,309,000 | — | 31 Mar 2022 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.22%
|
245,692
|
$3,897,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
244,650
|
$3,880,000 | — | 31 Mar 2022 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.22%
|
241,192
|
$3,826,000 | — | 31 Mar 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
218,107
|
$3,459,000 | — | 31 Mar 2022 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
207,174
|
$3,286,000 | — | 31 Mar 2022 | |
| Prosight Management, LP |
13F
|
Company |
0.19%
|
203,268
|
$3,224,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.18%
|
200,000
|
$3,172,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.18%
|
191,512
|
$3,037,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
174,197
|
$2,763,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
165,273
|
$2,621,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
156,500
|
$2,482,000 | — | 31 Mar 2022 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.14%
|
150,200
|
$2,396,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
142,011
|
$2,252,000 | — | 31 Mar 2022 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q2 2022
As of 30 Jun 2022,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,545,073 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, MAVERICK CAPITAL LTD, RA CAPITAL MANAGEMENT, L.P., Assenagon Asset Management S.A., and CITADEL ADVISORS LLC.
This page lists
141
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
142
Q2 2022 holders
141
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.